Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003010751 | SCV003709086 | uncertain significance | Inborn genetic diseases | 2021-11-29 | criteria provided, single submitter | clinical testing | The c.472G>T (p.A158S) alteration is located in exon 3 (coding exon 3) of the ATP2B3 gene. This alteration results from a G to T substitution at nucleotide position 472, causing the alanine (A) at amino acid position 158 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
ARUP Laboratories, |
RCV003649419 | SCV004563378 | uncertain significance | X-linked progressive cerebellar ataxia | 2023-11-03 | criteria provided, single submitter | clinical testing |